| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Rituximab |
利妥昔单抗 |
174722-31-7 |
详细
|
| Infliximab |
英夫利昔单抗 |
170277-31-3 |
详细
|
| ILK-IN-3 |
4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine |
6975-75-3 |
详细
|
| Masitinib mesylate |
马赛替尼 |
1048007-93-7 |
详细
|
| Tenovin-6 Hydrochloride |
TENOVIN 2 |
1011301-29-3 |
详细
|
| SEP-0372814 |
SEP-0372814 |
1516895-53-6 |
详细
|
| BMS-1001 |
BMS-1001 |
2113650-03-4 |
详细
|
| Metformin |
二甲双胍 |
657-24-9 |
详细
|
| THPP-1 |
THPP-1 |
1257051-63-0 |
详细
|
| 5-Methylfurfural |
5-甲基糠醛 |
620-02-0 |
详细
|
| Dantrolene |
旦著能 |
7261-97-4 |
详细
|
| NPS2390 |
NPS 2390 |
226878-01-9 |
详细
|
| Spinorphin |
SPINORPHIN |
137201-62-8 |
详细
|
| Tetrazole |
1H-四唑 |
27988-97-2 |
详细
|
| Pembrolizumab |
派姆单抗 |
1374853-91-4 |
详细
|
| AC1903 |
AC1903 |
831234-13-0 |
详细
|
| Omalizumab |
奥马珠单抗 |
242138-07-4 |
详细
|
| RA-9 |
(3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮 |
919091-63-7 |
详细
|
| 3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide |
化合物T8501 |
1252187-41-9 |
详细
|
| EIDD-1931 |
N-羟基胞苷 |
3258-02-4 |
详细
|
| UNC1079 |
1,4-伸苯基双(1,4'-二哌啶-1'-基甲酮) |
1418741-86-2 |
详细
|
| Daratumumab |
达妥木单抗 |
945721-28-8 |
详细
|
| TLR4-IN-C34 |
TLR4-IN-C34 |
40592-88-9 |
详细
|
| TC-I2000 |
化合物TC-I2000 |
1159996-20-9 |
详细
|
| Vanillic Acid |
香草酸 |
121-34-6 |
详细
|
| SX-682 |
SX-682 |
1648843-04-2 |
详细
|
| BMS-345541 hydrochloride |
N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐 |
547757-23-3 |
详细
|
| Vonafexor |
YP001 |
1192171-69-9 |
详细
|
| Enoximone |
依诺昔酮 |
77671-31-9 |
详细
|
| SC-236 |
4-(5-(4-氯苯基)-3-(三氟甲基)-1H- |
170569-86-5 |
详细
|
| Filastatin |
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone |
431996-53-1 |
详细
|
| CNQX disodium |
6-CYANO-7-NITROQUINOXALINE-2;3-DIONE DISODIUM |
479347-85-8 |
详细
|
| Empesertib |
BAY1161909 |
1443763-60-7 |
详细
|
| Vorolanib |
VOROLANIB |
1013920-15-4 |
详细
|
| Butoconazole |
布康唑 |
64872-76-0 |
详细
|
| β-Caryophyllene |
β-石竹烯 |
87-44-5 |
详细
|
| Pulegone |
长叶薄荷酮 |
89-82-7 |
详细
|
| CPYPP |
4-[3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione |
310460-39-0 |
详细
|
| Cysteine thiol probe |
Methyl (4-bromobenzoyl)-L-cysteinate |
1947408-74-3 |
详细
|
| IM156 |
IM156 |
1422365-93-2 |
详细
|
| Tyrphostin AG 112 |
TYRPHOSTIN A48 |
144978-82-5 |
详细
|
| Levomenol |
没药醇 |
23089-26-1 |
详细
|
| Bevacizumab |
贝伐珠单抗 |
216974-75-3 |
详细
|
| Yohimbine |
育亨宾 |
146-48-5 |
详细
|
| Matuzumab |
马妥珠单抗 |
339186-68-4 |
详细
|
| Nimotuzumab |
nimotuzumab |
828933-51-3 |
详细
|
| Lenvatinib mesylate |
乐伐替尼甲磺酸盐 |
857890-39-2 |
详细
|
| Nivolumab |
纳武单抗 |
946414-94-4 |
详细
|
| Alirocumab |
阿利库单抗 |
1245916-14-6 |
详细
|
| L-Alanine |
L-丙氨酸 |
56-41-7 |
详细
|
| ML382 |
2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide |
1646499-97-9 |
详细
|
| THIQ |
THIQ |
312637-48-2 |
详细
|
| CB1 antagonist 4 |
化合物TM38837 |
1253641-65-4 |
详细
|
| Avelumab |
阿维鲁单抗 |
1537032-82-8 |
详细
|
| Ripretinib |
瑞普替尼 |
1442472-39-0 |
详细
|
| MAZ51 |
CS-2885 |
163655-37-6 |
详细
|
| Vedolizumab |
维多珠单抗 |
943609-66-3 |
详细
|
| BC-DXI-843 |
化合物BC-DXI-843 |
2421117-98-6 |
详细
|
| LQZ-7I |
N2,N3-双(4-氟苯基)喹喔啉-2,3-二胺 |
195822-23-2 |
详细
|
| Trastuzumab |
曲妥珠单抗 |
180288-69-1 |
详细
|
| trans-Benzylideneacetone |
反式苯亚甲基丙酮 |
1896-62-4 |
详细
|
| Ustekinumab |
乌司奴单抗 |
815610-63-0 |
详细
|
| BENZYLACETONE |
苄基丙酮 |
2550-26-7 |
详细
|
| DL-Methionine |
DL-蛋氨酸 |
59-51-8 |
详细
|
| Adalimumab |
阿达木单抗 |
331731-18-1 |
详细
|
| ZSET1446 |
887603-94-3 |
887603-94-3 |
详细
|
| Ingliforib |
CPD2802 |
186392-65-4 |
详细
|
| Dehydroabietic acid |
脱氢松香酸 |
1740-19-8 |
详细
|
| ERK1/2 inhibitor 2 |
ASTX-029 |
2095719-92-7 |
详细
|
| Raphin1 acetate |
RAPHIN1 ACETATE |
2242616-04-0 |
详细
|
| SMCC |
4-(N-马来酰亚胺基甲基)环己烷-1-羧酸琥珀酰亚胺酯 |
64987-85-5 |
详细
|
| Ipilimumab |
伊匹单抗 |
477202-00-9 |
详细
|
| Dabrafenib Mesylate |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
详细
|
| Ramucirumab |
雷莫芦单抗 |
947687-13-0 |
详细
|
| Evolocumab |
依洛尤单抗 |
1256937-27-5 |
详细
|
| eCF506 |
1914078-41-3 |
1914078-41-3 |
详细
|
| 3-AQC |
化合物3-AQC |
201216-42-4 |
详细
|
| 2-Phenylacetaldehyde |
苯乙醛 |
122-78-1 |
详细
|
| Panitumumab |
帕尼单抗 |
339177-26-3 |
详细
|
| Obinutuzumab |
阿托珠单抗 |
949142-50-1 |
详细
|
| 2,5-Dihydroxyacetophenone |
2,5-二羟基苯乙酮 |
490-78-8 |
详细
|
| Cetuximab |
西妥昔单抗 |
205923-56-4 |
详细
|
| Denosumab |
迪诺苏单抗 |
615258-40-7 |
详细
|
| KN-92 hydrochloride |
KN-92 盐酸盐 |
1431698-47-3 |
详细
|
| Belinostat |
贝利司他 |
866323-14-0 |
详细
|
| Neryl acetate |
(Z)-3,7-二甲基-2,6-辛二烯-1-醇乙酸酯 |
141-12-8 |
详细
|
| DihydroarteMisinic acid |
二氢青蒿酸 |
85031-59-0 |
详细
|
| Atezolizumab |
阿特珠单抗 |
1380723-44-3 |
详细
|
| VLX600 |
VLX600 |
327031-55-0 |
详细
|
| m-3M3FBS |
2,4,6-三甲基-N-[3-(三氟甲基)苯基]苯磺酰胺 |
200933-14-8 |
详细
|
| DNQX disodium salt |
SODIUM 6;7-DINITROQUINOXALINE-2;3-BIS(OLATE);6;7-DINITROQUINOXALINE-2;3-DIONE DISODIUM SALT |
1312992-24-7 |
详细
|
| 2'-Hydroxyacetophenone |
2'-羟基苯乙酮 |
118-93-4 |
详细
|
| RET V804M-IN-1 |
化合物RET V804M-IN-1 |
2414909-94-5 |
详细
|
| WYC-210 |
2-((4,4-二甲基-1-氧化硫代苯并二氢吡喃-6-基)乙炔基)嘧啶-5-羧酸 |
2131803-93-3 |
详细
|
| 2-Pentylfuran |
2-正戊基呋喃 |
3777-69-3 |
详细
|
| Cyclic AMP |
环磷酸腺苷 |
60-92-4 |
详细
|
| Alemtuzumab |
阿伦单抗 |
216503-57-0 |
详细
|
| Ofatumumab |
奥法木单抗 |
679818-59-8 |
详细
|
| IQ-3 |
IQ 3 |
312538-03-7 |
详细
|
| SC-43 |
SC-43 |
1400989-25-4 |
详细
|